Search
for
Sort by
Research 91–120 of 1000+
- Structure and Expression of a New Complementary DNA Encoding the almost Exclusive 3β-Hydroxysteroid Dehydrogenase/Δ<sup>5</sup>-Δ<sup>4</sup>-lsomerase in Human Adrenals and Gonads
- Hyperandrogenism: Acne and Hirsutism
- Hyperandrogenism: Acne and Hirsutism
- Hyperandrogenism: Acne and Hirsutism
- Hyperandrogenism: Acne and Hirsutism
- Clinical Presentation of Polycystic Ovary Syndrome
- Acne Syndromes and Mosaicism
- Alternative androgen pathways
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Practical approaches to the use of markers of biochemical hyperandrogenism in women
- Nonclassic 21-hydroxylase deficiency
- An unusual circulating steroid profile in a virilized postmenopausal woman
- Hirsutism and Hypertrichosis
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Nonclassic adrenal hyperplasia
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- A recently characterized, underdiagnosed cause of female androgenetic alopecia and polycystic ovarian syndrome: non-classical 21 hydroxylase deficiency
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- PCOS and Obesity: Contraception Challenges
- MON-369 Treatment of Nonclassic 11-Hydroxylase Deficiency with "Hair, Skin, and Nails," an Over-the-Counter, Insulin Sensitizing Vitamin/Mineral Supplement
- Characteristics of phenotypes (clinical variants) of polycystic ovary syndrome in women of reproductive age
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- A Very Rare Reason for Hyperandrogenism: Adrenal Tumor Case